Mexico Makes Cardio-Renal-Metabolic Care Protocols Mandatory

Mexico's General Health Council made five cardio-renal-metabolic National Medical Care Protocols (PRONAM) mandatory for public health institutions effective Aug. 25, 2026, requiring implementation plans within 90 days. The measure links to the Universal Health Service coordination framework and targets diseases responsible for 80% of Mexico's chronic non-communicable disease burden. IMSS, ISSSTE, IMSS-Bienestar, and other public providers face new training, budgetary, and electronic-records obligations, creating near-term demand signals for medical device suppliers, hospital IT vendors, and health system integrators operating in Mexico's public sector.  

Mexico's General Health Council (CSG) made the implementation of five National Medical Care Protocols (PRONAM) covering cardio-renal-metabolic syndrome mandatory for public health institutions, according to the Official Gazette of the Federation (DOF). The rule enters into force Aug. 25, 2026, and gives institutions a maximum of 90 calendar days to submit institutional implementation plans.  

The mandate builds directly on an integrated clinical model the Ministry of Health began rolling out days earlier. Presenting the broader shift, Minister of Health David Kershenobich argues that chronic kidney disease, hypertension, and diabetes are closely linked conditions that should no longer be treated separately, since the appearance of one raises the risk of developing the others. This converts that clinical framing into a binding administrative obligation.  

The measure targets a disease cluster the CSG describes as Mexico's dominant chronic-illness burden. In its considerations, the Council states that chronic kidney disease, systemic hypertension, type 2 diabetes, dyslipidemias, and obesity together account for 80% of the country's chronic non-communicable disease burden. It cites the Ensanut Continua 2022 survey, which found that 18.4% of adults over age 20 had diabetes and 29.4% had hypertension. The document links the PRONAM to the Universal Health Service (SUS), created by presidential decree on Apr. 17, 2026, as a mandatory coordination mechanism among federal and state public health institutions. That decree, and the interoperability demands it places on Mexico's fragmented public system, which noted that 96% of health IT leaders in Mexico report serious obstacles connecting institutional records systems.  

Five instruments fall under the new obligation: the protocols for chronic kidney disease, systemic hypertension, type 2 diabetes and metabolic syndrome, and overweight and obesity, plus the umbrella Integration Route itself. The four individual protocols were previously approved and published by the CSG; only the integration route and the enforcement obligation are new. Institutions must undertake administrative, training, budgetary, and communication measures needed for compliance and must favor electronic systems, including electronic clinical records and electronic prescriptions, though the Mandate sets no specific budget allocation or single mandatory technology platform. The Ministry of Health, through its competent administrative units, will monitor compliance, and public institutions must supply requested information.  

The obligation applies exclusively to public institutions providing health services and does not extend to private hospitals, clinics, or practitioners. Institutions may depart from a protocol only where a documented medical contraindication exists; no other clinical exceptions are contemplated.

The mandate lands as Mexico's public system reports record activity. Public institutions delivered 101.2 million first-level consultations between January and July 2026, a 28% increase over the same period in 2022, alongside a 60% rise in specialty consultations. Officials have tied that volume growth to the same SUS coordination effort the CSG now links to the PRONAM mandate, suggesting the cardio-renal-metabolic protocols will be implemented against a backdrop of already-rising demand on IMSS, ISSSTE, and IMSS-Bienestar. For medical device suppliers, hospital operators, and health IT vendors, the 90-day planning window signals near-term procurement and training activity tied to protocol rollout, electronic-record adoption, and staff certification across the public system.